Skip to main content

Day: December 8, 2025

Transcontinental Inc. enters into Agreement to Sell its Packaging Business

MONTREAL, Dec. 08, 2025 (GLOBE NEWSWIRE) — Transcontinental Inc. (“TC Transcontinental” or the “Corporation”) (TSX: TCL.A, TCL.B) today announced that it has entered into a stock purchase agreement (the “Stock Purchase Agreement”) with ProAmpac Holdings Inc. (“ProAmpac”) and certain of its subsidiaries (collectively, the “Buyer”), pursuant to which the Buyer has agreed to purchase all of the issued and outstanding shares of capital stock of entities which carry on the business of the Corporation’s Packaging Sector (“TC Transcontinental Packaging” or the “Packaging Business”) (the “Transaction”). The Transaction will result in the divestiture of the Corporation’s entire interest in the Packaging Sector. All amounts in this press release are in Canadian dollars, unless indicated otherwise. The aggregate purchase price payable to...

Continue reading

Zelluna ASA: New share capital registered

Oslo, Norway, 8 December, 2025: Reference is made to the stock exchange announcement made by Zelluna ASA (the “Company”) on 3 November 2025 regarding the successful private placement of 5,500,000 new shares (the “Private Placement”), divided on a first tranche of 3,729,774 new shares and a second tranche of 1,770,226 new shares (“Tranche 2”), and the allocation of 315,639 new shares in the retail offering carried out via the PrimaryBid platform. The share capital increase pertaining to the issuance of the 1,770,226 new shares in Tranche 2 has now been registered with the Norwegian Register of Business Enterprises. The Company’s new share capital is NOK 26,269,801 divided into 26,269,801 shares, each with a par value of NOK 1. For further information, please contact: Namir Hassan, CEO, Zelluna...

Continue reading

Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026

IRVINE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to pre-release its topline fourth quarter 2025 financial results the week of January 5, 2026. Topline financial results covered in the pre-release are expected to include net sales, new patient starts, and the percentage of new patient starts reimbursed through the pharmacy benefit plan (PBP) channel. Members of the Company’s management team will host in-person meetings in San Francisco from January 12, 2026 through January 14, 2026 to discuss topline fourth quarter 2025 results. The Company invites investors to register for in-person meetings by contacting the Company’s investor relations representative at ir@betabionics.com. About...

Continue reading

ContextLogic to Acquire US Salt from Emerald Lake in $907.5 Million Transaction, Creating New Business Ownership Platform in Partnership with Abrams Capital and BC Partners Credit

Marks the first step in building ContextLogic into a differentiated business ownership platform.  ContextLogic will be focused on owning niche, competitively-advantaged, long-duration businesses run by world-class management teams. US Salt, the first such acquisition, is a 132-year old business producing high-purity evaporated salt products for recession-resilient end markets. Led by a management team with 25+ year record of value creation, US Salt has consistently delivered strong revenue growth, robust margins, and high cash flow generation. ContextLogic shareholders will have the opportunity to commit additional capital in the transaction via a rights offering, which has been fully backstopped by Abrams Capital and BC Partners at $8 per share.  OAKLAND, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — ContextLogic Holdings Inc.,...

Continue reading

Eimskip’s Financial Calendar 2026

Eimskip’s Financial Calendar 2026Management financial results for 2025    28. January 2026Fourth quarter 2025, Financial results for 2025 and sustainability statement 3 March 2026Annual General Meeting 2026 26 March 2026First quarter 2026                                      5 May 2026Second quarter 2026                                   25 August 2026Third quarter 2026                                    13 November 2026Management financial results for 2026    2 February 2027Fourth quarter 2026, Financial results for 2026 and sustainability statement 9 March 2027Annual General Meeting 2027 1 April 2027Financial results will be disclosed and published after market closing.Please note that dates are subject to change. For further information please contact Guðbjörg Birna Björnsdóttir,...

Continue reading

Tecnoglass to Attend the Raymond James 2025 TMT & Consumer Conference

Miami, FL, Dec. 08, 2025 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that the Company will attend the Raymond James 2025 TMT & Consumer Conference in New York, NY on Wednesday, December 10, 2025. About Tecnoglass Tecnoglass Inc. is a leading producer of high-end aluminum and vinyl windows and architectural glass serving the multi-family, single-family, and commercial end markets. Tecnoglass is the second largest glass fabricator serving the U.S. and the #1 architectural glass transformation company in Latin America. Located in Barranquilla, Colombia, the Company’s 5.8 million square foot, vertically integrated,...

Continue reading

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment

MOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a newly published study in Translational Vision Science & Technology (TVST) examining the thermal dynamics of transscleral laser treatments for glaucoma.1 Led by Tomas M. Grippo, MD, of the Grippo Glaucoma & Cataract Center (Buenos Aires, Argentina), the study provides the first quantitative computer model comparing the thermal tissue effects of continuous wave transscleral cyclophotocoagulation (CW-TSCPC) and transscleral laser therapy using MicroPulse® technology (MicroPulse TLT) with Iridex’s Cyclo G6® Laser, G-Probe® and MicroPulse P3® delivery...

Continue reading

OTC Markets Group Welcomes Bimini Capital Management, Inc. to OTCQX

NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bimini Capital Management, Inc. (OTCQX: BMNM), an asset manager that speacilizes in residential mortgage-related securities, has qualified to trade on the OTCQX® Best Market. Bimini Capital Management, Inc. upgraded to OTCQX from the OTCQB® Venture Market. Bimini Capital Management, Inc. begins trading today on OTCQX under the symbol “BMNM.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market provides investors with a premium U.S. public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market marks an important milestone...

Continue reading

Mercury Showcases Expanding Portfolio of Electronic Warfare Capabilities at AOC 2025

ANDOVER, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a global technology company that delivers mission-critical processing to the edge, will participate in this week’s Association of Old Crows (AOC) International Symposium and Convention, showcasing the company’s expanding portfolio of electronic warfare (EW) capabilities and sharing key insights during conference sessions. AOC 2025 is the premier event for electronic warfare, electromagnetic spectrum operations, cyber-electromagnetic activities, and information operations professionals from around the world. During the symposium, Mercury leaders will explore this year’s theme, Charting a Path to 2035: Navigating the Future of Electromagnetic Spectrum Operations.Dr. Bill Conley, Mercury’s Chief Technology Officer, will participate...

Continue reading

PyroGenesis Confirms Half-Tonne Order for Immediate Delivery of Titanium Metal Powder

Represents first contract under Approved Supplier Status with Global Aerospace Leader MONTREAL, Dec. 08, 2025 (GLOBE NEWSWIRE) — PyroGenesis Inc. (“PyroGenesis”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), the leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today the recent signing of a half-tonne contract with a Global Aerospace Leader for the supply of titanium metal powder produced by PyroGenesis’ NexGen™ plasma atomization process. This contract was achieved as part of a competitive bid process, and represents the first order received since official supplier status was granted to PyroGenesis by the client after a multi-year certification process. The contract is for the supply of “coarse” cut Ti64 powder (particle size:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.